Follow The Filings

IBIO

Health Care, filed as IBIO INC (COM NEW), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $298K
  • 1 reduce

In 2026 Q2 Nathan Fischel trimmed IBIO.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel Reduce 0.06%

Who owns IBIO

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.06%, was 0.09% Reduce −12.2% 170,053 $298K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by IBIO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IBIO insider trades
  • $98K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Marc Banjak Chief Legal Officer
    Buy
    $23K 13,934 shares at $1.65 +126% to stake
    Traded Mar 26 Filed Mar 27
    ↗
  2. Felipe Duran CFO
    Buy
    $50K 24,835 shares at $2.02 +223% to stake
    Traded Mar 19 Filed Mar 23
    ↗
  3. Martin Brenner See Remarks
    Buy
    $25K 12,336 shares at $2.02 +67% to stake
    Traded Mar 19 Filed Mar 23
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,5.03,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 5.08,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
424B3 Filing Doc

Source: SEC EDGAR submissions, updated 9 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue — $225,000 $400,000 $100,000
Net income — -$24.91M -$18.38M -$33.04M
Net margin * — -11069.8% -4594.3% -33044.0%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $26.26M $15.67M $9.72M $92.22M
Total non-current assets * $14.95M $13.06M $13.46M $6.89M
Total assets $41.21M $28.73M $23.18M $99.11M
Total current liabilities $21.58M $3.84M $6.11M $11.74M
Total non-current liabilities * $4.24M $3.57M $2.2M $1.65M
Total equity $15.38M $21.32M $14.88M $85.71M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations -$30.44M -$18.55M -$15.3M -$23.22M
Cash from investing $7.01M $0.906M $0.742M -$32M
Cash from financing $2.3M $24.49M $8.93M $103.05M
Net change in cash -$21.09M $6.85M -$5.63M $47.83M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.